DrugPatentWatch Database Preview
LEVOCARNITINE - Generic Drug Details
» See Plans and Pricing
What are the generic sources for levocarnitine and what is the scope of freedom to operate?
Levocarnitine
is the generic ingredient in four branded drugs marketed by Leadiant Biosci Inc, Am Regent, Teva Pharms Usa, West-ward Pharms Int, Akorn, Lyne, Novitium Pharma, and Rising, and is included in ten NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Levocarnitine has four patent family members in four countries.
There are four drug master file entries for levocarnitine. Five suppliers are listed for this compound.
Summary for LEVOCARNITINE
| International Patents: | 4 |
| US Patents: | 3 |
| Tradenames: | 4 |
| Applicants: | 8 |
| NDAs: | 10 |
| Drug Master File Entries: | 4 |
| Suppliers / Packagers: | 5 |
| Bulk Api Vendors: | 96 |
| Clinical Trials: | 10 |
| Patent Applications: | 7,406 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for LEVOCARNITINE |
| What excipients (inactive ingredients) are in LEVOCARNITINE? | LEVOCARNITINE excipients list |
| DailyMed Link: | LEVOCARNITINE at DailyMed |
Recent Clinical Trials for LEVOCARNITINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mabaret Al-Asafara Hospitals | Phase 4 |
| Vanderbilt University Medical Center | Phase 2 |
| University of Guadalajara | Phase 2 |
Pharmacology for LEVOCARNITINE
| Drug Class | Carnitine Analog |
US Patents and Regulatory Information for LEVOCARNITINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn | LEVOCARNITINE | levocarnitine | SOLUTION;ORAL | 077399-001 | Oct 25, 2007 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lyne | LEVOCARNITINE | levocarnitine | SOLUTION;ORAL | 076851-001 | Aug 10, 2004 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | AP | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Leadiant Biosci Inc | CARNITOR | levocarnitine | SOLUTION;ORAL | 019257-001 | Apr 10, 1986 | AA | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| West-ward Pharms Int | LEVOCARNITINE | levocarnitine | INJECTABLE;INJECTION | 075567-001 | Mar 29, 2001 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LEVOCARNITINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | Start Trial | Start Trial |
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | Start Trial | Start Trial |
| Leadiant Biosci Inc | CARNITOR | levocarnitine | INJECTABLE;INJECTION | 020182-001 | Dec 16, 1992 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LEVOCARNITINE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 3050201 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0152836 | Start Trial |
| European Patent Office | 1257266 | Start Trial |
| Canada | 2381187 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
